대한뉴팜

Daehan New Pharm (CEO Park Myung-rae) held the “2004 Mountain March Competition” on the 4th to establish a sense of purpose and strengthen the sales organization. The event took place on a 60km mountain march course from Yanggu, Gangwon Province, to Inje and Hyeon-ri, with about 130 participants from the sales and sales support departments, including CEO Park. The march, which started at midnight after a sales meeting on the 3rd, was conducted along National Road 31, crossing the now-closed old Gwangchiryung Pass to reach Inje and Hyeon-ri. This route, known as the “hell march course,” typically takes about 15 hours and is known to be challenging even for frontline soldiers. The march was organized by small sales teams that encouraged and pushed each other, and all participants completed the march without anyoneping out in about 15 hours. Notably, three female employees voluntarily participated and completed the march alongside their male colleagues. Participant Lee Chae-il (36), team leader of the Ulsan team, said, “Remembering the spirit of my military service 10 years ago, I reflected on my somewhat lax attitude so far and had a good experience strengthening camaraderie with colleagues who sweat together in the sales field. Based on this spirit and organizational strength, I will do my best to achieve the given targets." Since its listing on KOSDAQ, Daehan New Pharm has been solidifying its sales foundation through sound growth, securing excellent talents, and intensive training. The company plans to continue developing similar mental education programs to maintain organizational strength.

Daehan New Pharm obtained the license for 'Health Functional Food Specialized Manufacturing Business' on August 23, 2004.

Daehan New Pharm (CEO Park Myung-rae) has launched a new liver disease treatment called "Eldamin Soft Capsules," which contains silymarin along with a complex of B vitamins. Silymarin, extracted from Carduus marianus, has been traditionally used as a folk remedy for liver diseases and is known for its excellent effects in protecting the liver from damage, promoting liver cell regeneration, and aiding liver detoxification. The capsules also include six types of B vitamins (B1, B2, B3, B5, B6, B12) that are formulated to support liver function recovery, alleviate fatigue, and help prevent various adult diseases common in modern life. Daehan New Pharm aims to boost pharmacy sales by complementing its existing herbal natural drug lineup and Western OTC products with this new release. The premium packaging sets the consumer price at about 60,000 to 80,000 KRW per bottle (300 capsules), which is expected to contribute to sales at the pharmacy level.

Daehan New Pharm (CEO Park Myung-rae) held the ‘A+ 2004! Management Strategy Seminar and Mountaineering Competition’ over two days on the 2nd and 3rd, aimed at establishing a sense of purpose and revitalizing sales activities. The event took place at Lake Hills Hotel in Songnisan, with about 170 participants including all employees from sales and administrative departments, excluding production site staff. On the first day, participants completed a circuit around Moonjangdae and Sinsendae in Songnisan within about seven hours, with noouts. This was followed by a night of unity, reinforcing the strength of an organized team. The next day’s management strategy seminar involved in-depth discussions on strategies for achieving second-half and full-year 2004 goals, and included the ‘A+ 2004! Management Strategy Declaration Ceremony.’ An awards ceremony for outstanding employees of the first half was also held, where winners received overseas training opportunities in Southeast Asia. Special guest Lee Hee-goo, chairman of Geo Young and former head of the Wholesale Association, delivered a keynote lecture on ‘Salesperson Strategies and Attitudes amid the Pharmaceutical Industry’s Development.’ Chairman Lee encouraged participants to take pride and responsibility in their roles as contributors to public health, despite the many changes and challenges in the domestic pharmaceutical industry environment. Lee Sang-pil, branch manager of Gwangju who received an award for outstanding employee, expressed that the seminar was a meaningful opportunity to reflect on himself and feel limitless possibilities and pride in the company. Since listing on KOSDAQ, Daehan New Pharm has been achieving substantial growth based on the successful establishment of specialty and herbal medicine markets.

Daehan New Pharm (CEO Park Myung-rae) held the 2004 Goal Achievement Rally on March 9th and 10th at the Korea Human Resources Development Institute in Giheung, Gyeonggi Province. Around 150 employees from sales-related departments attended the event, where the first-quarter results were analyzed and plans for achieving the annual goals were reviewed. CEO Park urged all employees to actively respond to changes and to do their best to achieve the goals for the company to advance as a leading, prosperous enterprise. The rally included presentations and evaluations of first-quarter performance and plans for the second to fourth quarters by the Pharmaceutical Business Division, Herbal Medicine Business Division, Animal Medicine Business Division, Bio Business Division, and Overseas Business Division. Unlike previous monthly sales meetings held separately by each division, this event brought together all five divisions along with its affiliate Avent Korea for joint participation. The event also featured discussions on methods for achieving targets by product and client, strategies for recovering bad debts, and detailed action plans formulated through breakout sessions.

Daehan New Pharm (CEO Park Myung-rae) implemented a major promotion on the 6th, appointing Son Young-wook as Executive Director in charge of Animal Medicine Sales and Park Eun-ho as Executive Director in charge of Administration. This promotion is part of a larger personnel move across all five divisions—Pharmaceuticals, Animal Medicine, Herbal Medicine, Biohealth, and Industrial—that aims to strengthen responsibility and authority to further solidify the company’s status as a leading mid-sized pharmaceutical firm after exceeding sales targets in 2004. A company spokesperson stated, "Through this personnel move, we will further strengthen an autonomous responsibility management system by division and establish a stable growth foundation under the leadership of each business division head." The promotion list is as follows: Executive Directors: Son Young-wook (Sales Headquarters), Park Eun-ho (Management Headquarters) Department Heads: Yoon Ho-yong (Herbal Medicine Sales) and six others Deputy General Managers: Lee Young-hak (Pharmaceutical Sales) and eight others Managers: Kang Doo-seok (Animal Medicine Production) and four others Assistant Managers: Kim Sang-goo (Pharmaceutical Production) Senior Staff: Kim Jae-hyuk (Production Management) and one other

Daehan New Pharm Reappoints CEO Park Myung-rae; Elects Lee Cheon-soo as New Vice President and Choi Sung-sook as Auditor Daehan New Pharm held its 20th regular shareholders' meeting at the Hyangnam Pharmaceutical Complex in Hwaseong, Gyeonggi Province, on the 22nd andd a cash dividend of 50 won (10%). At the meeting, incumbent CEO Park Myung-rae was reappointed, while Lee Cheon-soo was elected as the new director (Vice President), and Choi Sung-sook was elected as the new auditor. Daehan New Pharm's annual sales for the previous year reached 37.823 billion KRW, marking an increase of 20.11% compared to the previous year. Operating profit increased by 8.54% to 2.566 billion KRW, while ordinary profit decreased by 8.35% to 1.986 billion KRW, and net profit decreased by 11.76% to 1.410 billion KRW. CEO Park Myung-rae stated, "Daehan New Pharm is actively pursuing company-wide activities to discover new value-added businesses, alongside implementing innovation programs aimed at cost reduction and quality improvement of existing products. We will strive to achieve management performance that meets the expectations of our shareholders."

Daehan New Pharm (CEO Park Myung-rae) held the induction ceremony for the 3rd cohort of new employees at the headquarters' main conference room on the 2nd. About 30 new employees began an intensive two-week training program. The training, held at the Korea Human Resources Development Institute in Giheung, Gyeonggi Province, covers basic pharmaceutical industry education including an introduction to the pharmaceutical environment and department-specific product academic sessions. After completing the first phase of the residential training on the 16th, the second phase of on-site training will follow in each respective department. In his congratulatory address, CEO Park emphasized, "The future of the company depends on the sound judgment and proactive actions of the new employees." He urged the new hires to fully dedicate themselves to the training with a strong spirit of challenge to achieve self-realization and become the leaders who will build a first-class company.

Daehan New Pharm successfully held a New Year's executive hiking event on the morning of the 17th. The hiking event covered the round trip course of Gwanaksan Mountain in Gwacheon. Despite heavy snowfall throughout the morning, all participants reached the summit without a singleout. Through this hiking event, Daehan New Pharm reaffirmed its commitment to achieving its 2004 goals and pledged to dedicate itself to building a new corporate culture through united teamwork.